Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Vascular Graft Market Research by Raw Material (Polyester Grafts, EPTFE Grafts, Polyurethane Grafts, Biosynthetic Grafts), Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair, Hemodialysis Access), End-user (Hospitals, Ambulatory Surgical Centers), and Region- Forecast till 2032


ID: MRFR/MED/5184-HCR | 100 Pages | Author: Rahul Gotadki| April 2024

Global Vascular Graft Market Overview


According to market research future, the Vascular Graft Market would increase USD 5.9 billion at a CAGR of 7% between 2023 and 2032. Vascular graft or vascular bypass is a surgical procedure that reroutes blood from one location of normal blood flow to another area of generally normal blood flow in order to bypass a damaged artery. Depending on the indication and the raw materials used to produce the graft, there are many vascular grafts available. Vascular grafts are utilized to provide hemodialysis access as well as to treat aneurysms, especially thoracic aneurysms, endovascularly.


The high incidence of abdominal aneurysms, the expanding geriatric population, and the rising prevalence of smoking and other aneurysm risk factors are the key drivers driving the growth of this market. These illnesses include atherosclerosis, pulmonary embolism, deep vein thrombosis, and other heart ailments, as well as a growth in the number of hospitals and surgery centers, which makes disease detection and treatment easier.


Vascular Graft Market Segment Insights


The global vascular graft market has been segmented on the basis of raw material, indication, end-user, and region.


Based on raw material, the global market of vascular graft has been segmented into polyester grafts, EPTFE grafts, polyurethane grafts, and biosynthetic grafts. While polyester grafts hold the major market share among all the segments, biosynthetic graft is considered to be the fastest growing segment.


Based on indication, the global market of vascular graft has been segmented into endovascular aneurysm repair, peripheral vascular repair, and hemodialysis access. Endovascular aneurysm repair is considered to be the major segment among all the segments. The peripheral vascular repair segment is expected to be the fastest growing segment.


Based on end-user, the global market of vascular graft has been segmented into hospitals and ambulatory surgical centers. Among these, the hospitals hold the major segment and are anticipated to maintain its dominance during the review period. The ambulatory surgical centers are the fastest growing segment across the globe.


Vascular Graft Market Regional Insight


The global vascular graft market span across four major regions, namely Americas, Europe, Asia-Pacific, and Middle East & Africa.


America dominates the global vascular graft market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the high prevalence of cardiovascular diseases, diabetes, and chronic kidney diseases. With the availability of state-of-the-art healthcare infrastructure and presence of reimbursement coverage, the market is set to flourish. Asia Pacific is presumed to register the fastest market growth owing to the growing prevalence of diabetes and cardiovascular diseases in this region. Also improving healthcare infrastructure and epidemiological transition which has resulted in high rate of premature death is anticipated to trigger the demand for minimally invasive grafting procedures.


Key companies in the market of vascular graft include




  • Cardinal Health (US)

  • Gore Medical (US)

  • Terumo (Japan)

  • C. R. Bard (US)


  • Medtronic (Ireland)

  • LeMaitre Vascular (US)

  • B. Braun Melsugen AG (Germany)

  • Endologix (US)

  • Maquet (Germany)

  • Cook Medical (US)


Recent Development



In November 2023,


Terumo Announced the launch of the ENTHEON™ Neo Stent Graft System, a next-generation stent graft for the endovascular repair of abdominal aortic aneurysms (AAAs)

In December2023,


Medtronic Announced the launch of the Valiant® Monorail Stent Graft System, a next-generation stent graft for the treatment of complex aortic and iliac occlusive disease.



Cardinal Health Inc (Cardinal Health) is an integrated healthcare product and service provider. It sells branded and generic pharmaceuticals, specialty medications, over-the-counter healthcare, and consumer items, medical equipment, surgical instruments, and laboratory equipment. It also runs nuclear pharmacies and cyclotrons and develops its own private label medicinal and surgical items. Its expertise is divided into four categories: logistics, product, business, and patient solutions. The corporation has operations in the United States, Canada, Europe, etc. Cardinal Health is based in Dublin, Ohio, in the United States.

Vascular Graft Raw Material Outlook



  • Polyester Grafts

  • EPTFE Grafts

  • Polyurethane Grafts

  • Biosynthetic Grafts


Vascular Graft Indication Outlook



Vascular Graft End User Outlook



  • Hospitals

  • Ambulatory Surgical Centers


Vascular Graft Region Outlook



  • Americas

  • Europe

  • Asia Pacific

  • Middle East & Africa


Research Methodology


Data analysts at Market Research Future ensure objective analysis of the market while preparing market research reports by engaging set of standards which allow a comprehensive view of the market and its several components. Several factors comprising economic growth, government expenditure, supply channels and distribution channels have been scrutinized effort to relay precise information. Also, market-size estimation and validation use top-down and bottom-up approaches in order to obtain data from the demand and supply side. Analysis of data have been performed by using research framework suited to the specific industry. The frameworks are developed by the MRFR team which serves as a research standard that provides tools to create dependable market reports.

Report Attribute/Metric Details
  Market Size   2032: USD 5.9 Billion
  CAGR   7% CAGR (2023-2032)
  Base Year   2021
  Forecast Period   2023-2032
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Raw material, Indication, End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).
  Key Market Opportunities ·  High treatment cost·  Complications related to prosthetic grafts
  Key Market Drivers ·  Increasing prevalence of cardiac diseases, end-stage renal diseases·  Growing prevalence of diabetes, coronary artery diseases, cardiac aneurysms, and hypertension


Frequently Asked Questions (FAQ) :

The vascular graft market is projected to grow at an 7% CAGR between 2023-2032.

Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).

The vascular graft market predicted to touch USD 5.9 billion by 2032

The Americas is projected to command the largest share in the vascular graft market.

Different strategies used by market players to create a dominance in the vascular graft market include collaborations, product development, strategic alliances, and others.

Hospitals will lead the vascular graft market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization